Repression of the MSP/MST-1 gene contributes to the antiapoptotic gain of function of mutant p53

A Zalcenstein1, L Weisz, P Stambolsky

  • 1Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.

Oncogene
|September 20, 2005
PubMed

Insights

Mutant p53 suppresses the expression of the MSP gene, a ligand for the RON receptor tyrosine kinase. This repression confers cancer cell resistance to death, suggesting a role for mutant p53 in oncogenesis.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Tumor-associated mutant p53 proteins can gain antiapoptotic functions, aiding tumor cell survival.
  • The MSP gene encodes a ligand for the RON receptor tyrosine kinase, involved in cellular signaling.
  • Aberrant RON signaling is linked to tumor progression, yet reduced MSP expression is observed in many cancers.

Purpose of the Study:

  • To investigate the regulatory relationship between mutant p53 and MSP gene expression.
  • To determine the functional consequences of MSP downregulation by mutant p53 on cancer cell survival.

Main Methods:

  • Analysis of mutant p53's association with the MSP gene promoter.
  • Measurement of MSP mRNA and secreted protein levels following mutant p53 interaction.
  • Assessment of cell death resistance in cancer cells with downregulated MSP expression.

Main Results:

  • Mutant p53 directly represses the transcriptional activity of the MSP gene promoter.
  • This repression leads to decreased MSP mRNA and secreted protein levels.
  • Downregulation of MSP confers resistance to etoposide-induced cell death in lung carcinoma cells.

Conclusions:

  • Mutant p53-mediated repression of MSP gene expression contributes to cancer cell survival.
  • This mechanism may play a cell type-specific role in oncogenesis.
  • Findings reconcile the pro-survival role of RON with reduced MSP levels in cancer.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...